April 23, 2020 / 7:17 AM / a month ago

BRIEF-Selectimmune Pharma: Results From Clinical Study With IL-1 Receptor Inhibitors

April 23 (Reuters) - Selectimmune Pharma AB:

* RESEARCHERS AT LUND UNIVERSITY ARE NOW PUBLISHING RESULTS FROM CLINICAL STUDY IN WHICH IL-1 RECEPTOR INHIBITORS HAVE BEEN USED TO TREAT PATIENTS WITH CHRONIC LOWER URINARY TRACT PAIN (INTERSTITIAL CYSTITIS)

* STUDY SHOWS STRONG POSITIVE CLINICAL EFFECTS ON SYMPTOM AND LIFE QUALITY Source text for Eikon: Further company coverage: (Gdansk Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below